Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Novartis SWX:NOVN |
238,18 B | 3,02% | 5/6 | 0,20% | -32,17% | -7,80% | UP |
|
Galderma Group SWX:GALD |
36,77 B | 21,32% | 1/2 | 20,67% | -44,33% | 19,28% | UP |
|
Sandoz Group SWX:SDZ |
27,98 B | 22,64% | 0/0 | 12,84% | -96,40% | -2,26% | UP |
|
Galenica SWX:GALE |
4,65 B | 4,72% | 4/6 | 6,08% | -20,47% | -4,56% | UP |
|
Siegfried Holding SWX:SFZN |
3,51 B | 12,27% | 5/6 | 11,18% | 19,24% | 32,79% | DOWN |
|
Santhera Pharmaceuticals Holding SWX:SANN |
0,23 B | -46,21% | 3/6 | 47,64% | -154,18% | 84,73% | UP |
|
Perfect Holding SWX:PRFN |
0,01 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Addex Therapeutics Ltd SWX:ADXN |
0,01 B | -47,42% | 4/5 | 0,00% | 58,42% | -100,00% | DOWN |
|
NLS Pharmaceutics NasdaqCM:NLSP |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
GeNeuro ENXTPA:GNRO |
0,00 B | 0,00% | 3/5 | 0,00% | 0,00% | -100,00% | DOWN |
